Trulicity® (dulaglutide) and headache

Why the US table leaves headache out

Each regulator sets its own rule for which reactions reach the main table. The US Table 1 pools placebo-controlled trials of 0.75 mg and 1.5 mg in 1,670 adults, with an average exposure of about 24 weeks, and keeps only reactions reported by at least 5% of people on Trulicity® and more often than on placebo. ^[1] Seven rows qualify: five digestive reactions, decreased appetite and fatigue. Headache is absent, and the separate table for the 3 mg and 4.5 mg doses does not mention it either. ^[1]

The European summary ranks reactions by frequency class and has no headache entry. ^[3] The Canadian monograph casts a wider net: its Table 2 counts treatment-emergent adverse events, meaning anything reported during treatment whether or not the medicine caused it, from 1% upward. ^[4] That is the only document that gives headache a number.

Reading a one-point difference

On 0.75 mg, slightly fewer people reported headache than on placebo; on 1.5 mg, about one more person in a hundred did. ^[4] Across the longer studies, which compared Trulicity® with other diabetes treatments as well as placebo, the 1.5 mg figure sat a little above the comparators and the 0.75 mg figure a little below. ^[4] A pattern this flat is hard to tie to the medicine, which fits with headache staying out of the US and EU tables. ^[1][3]

Headache did come up in two early studies. In a 5-week dose-finding study of dulaglutide, then known as LY2189265, 43 people received weekly doses from 0.05 mg to 8 mg, some well above today’s maximum of 4.5 mg, and headache was the second most reported event after nausea. ^[5] In a 26-week trial of Trulicity® 1.5 mg against daily liraglutide 1.8 mg, nausea, diarrhoea and headache were the three most frequent events overall. ^[4] Neither summary splits headache by treatment group, so they show how often it was reported, not whether dulaglutide caused it.

How a weekly dulaglutide pen could lead to a headache

• Fluid loss (in the label): nausea, vomiting and diarrhoea are the commonest Trulicity® reactions, and the label warns that the dehydration they cause has led to kidney injury, mostly while treatment starts or the dose rises. ^[1] MedlinePlus lists headache among the signs of mild to moderate dehydration. ^[10] One published case described a patient with three days of headache and blurred vision after three weeks of dulaglutide and ongoing vomiting; the doctors linked a clot in a brain vein to severe dehydration. ^[6] A single case cannot prove cause, but it shows why headache with persistent vomiting deserves attention.
• Low blood sugar (in the label, with some combinations): with insulin or a sulfonylurea the risk rises, and the Medication Guide lists headache among the signs. ^[1][2] In placebo-controlled studies, readings below 54 mg/dL occurred in 3.3% on 1.5 mg with glimepiride (0% on placebo) and 14.7% on 1.5 mg with insulin glargine (9.3% on placebo). ^[1]
• Eating less (in the label, indirect): decreased appetite was reported by 4.9% on 0.75 mg and 8.6% on 1.5 mg, against 1.6% on placebo. ^[1] For people on insulin or a sulfonylurea, smaller meals can add to the low blood sugar risk above. ^[9]
• Caffeine, alcohol and sleep (general): MedlinePlus names caffeine withdrawal, lack of sleep and alcohol as migraine triggers. ^[7] If you cut back on coffee or changed your routine when you started Trulicity®, note that too.
• Where in the week (label fact, untested link): dulaglutide reaches its highest blood level 24 to 72 hours after a dose, with a median of 48 hours, and its half-life is about 5 days. ^[1] No study ties headache to that window; a log simply shows whether yours follows the injection.

Headaches that have nothing to do with Trulicity®

MedlinePlus describes tension headache as the most common type, linked to tight muscles in the neck, shoulders, scalp and jaw, and to stress, low mood, anxiety or awkward posture. ^[7] Migraine tends to throb on one side, often with light or sound sensitivity and nausea. Rebound headaches can follow taking pain medicine more than 3 days a week, sinus headaches worsen when bending forward, and colds, flu, fever and premenstrual syndrome can all bring one on. ^[7]

Rare but serious causes include very high blood pressure, bleeding in or around the brain, infection and sleep apnoea. ^[7] Because migraine itself often brings nausea, a migraine in the first weeks of Trulicity® can be mistaken for a stomach side effect, or the other way round. Noting which came first helps your prescriber sort them out.

Easing a headache: what public health sources describe

For a migraine, MedlinePlus suggests drinking water, especially after vomiting, resting in a quiet dark room, placing a cool cloth on the head and using any relaxation techniques you know. ^[7] It mentions acetaminophen, aspirin or ibuprofen for tension headaches and asks you to talk to your provider if you need pain medicine 3 or more days a week. ^[7] Cleveland Clinic says a dehydration headache usually eases within a few hours of sipping fluids and resting, advises avoiding caffeinated drinks while dehydrated, and suggests seeing a provider if it does not improve. ^[8]

For Trulicity® specifically, the Medication Guide asks you to drink fluids to lower the chance of dehydration and to let your provider know about nausea, vomiting or diarrhoea that persists. ^[2] If you use insulin or a sulfonylurea, the label asks that you learn the signs of low blood sugar and how to treat it; the dose of those medicines may be lowered when Trulicity® starts. ^[1][2] Check with a pharmacist before adding a painkiller. The European information notes that dulaglutide slowed paracetamol absorption after the first dose but had no meaningful effect once dosing was steady. ^[3]

Trulicity® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.